Edgewise Therapeutics Inc.
EWTX | NASDAQ
$45.14
+$0.50 (+1.12%)
Sep 22, 2026, 1:45 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 590K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -590K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -61.94M | -54.12M | -55.98M | -46.86M | -42.61M | -45.96M | -45.54M | -40.43M | -38.11M | -34.75M | -33.86M | -29.45M | -25.34M | -25.7M | -22.08M | -18.26M | -16.49M | -14.83M | -12.82M | -13.08M | -10.46M | -6.86M |
Interest Income | 4.62M | 5.1M | 5.76M | 6.19M | 6.5M | 5.16M | 5.88M | 6.3M | 6.61M | 6.23M | 3.72M | 3.74M | 3.87M | 2.87M | 2.66M | 764K | 424K | 166K | 126K | 127K | 107K | 42K |
Pretax Income | -57.33M | -49.01M | -50.22M | -40.67M | -36.12M | -40.8M | -39.66M | -34.13M | -31.5M | -28.53M | -30.14M | -25.71M | -21.47M | -22.84M | -19.42M | -17.5M | -16.07M | -14.66M | -12.7M | -12.95M | -10.35M | -6.82M |
Net Income | -57.33M | -49.01M | -50.22M | -40.67M | -36.12M | -40.8M | -39.66M | -34.13M | -31.5M | -28.53M | -30.14M | -25.71M | -21.47M | -22.84M | -19.42M | -17.5M | -16.07M | -14.66M | -12.7M | -12.95M | -10.35M | -6.82M |
Selling & General & Admin | 14.4M | 11.46M | 12.39M | 9.38M | 9.05M | 9.2M | 9.17M | 8.21M | 7.43M | 7.06M | 6.18M | 5.67M | 5.78M | 5.83M | 5.47M | 4.37M | 4.09M | 3.7M | 3.73M | 3.2M | 2.6M | 1.5M |
Research & Development | 47.55M | 42.65M | 43.59M | 37.48M | 33.56M | 36.76M | 36.37M | 32.22M | 30.68M | 27.69M | 27.68M | 23.79M | 19.56M | 19.88M | 16.61M | 13.89M | 12.4M | 11.12M | 9.09M | 9.88M | 7.86M | 5.36M |
Other Expenses | n/a | -590K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 61.94M | 53.53M | 55.98M | 46.86M | 42.61M | 45.96M | 45.54M | 40.43M | 38.11M | 34.75M | 33.86M | 29.45M | 25.34M | 25.7M | 22.08M | 18.26M | 16.49M | 14.83M | 12.82M | 13.08M | 10.46M | 6.86M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 61.94M | 54.12M | 55.98M | 46.86M | 42.61M | 45.96M | 45.54M | 40.43M | 38.11M | 34.75M | 33.86M | 29.45M | 25.34M | 25.7M | 22.08M | 18.26M | 16.49M | 14.83M | 12.82M | 13.08M | 10.46M | 6.86M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 107.67M | 107.12M | 102.93M | 105.49M | 104.94M | 95.13M | 92.41M | 93.81M | 93.52M | 87.57M | 64.77M | 63.46M | 63.38M | 63.27M | 63.23M | 51.84M | 49.62M | 49.54M | 49.26M | 49.26M | 49.26M | 49.26M |
Shares Outstanding (Diluted) | 107.67M | 107.12M | 102.93M | 105.49M | 104.94M | 95.13M | 92.41M | 93.81M | 93.52M | 87.57M | 64.77M | 63.46M | 63.38M | 63.27M | 63.23M | 51.84M | 49.62M | 49.54M | 49.26M | 49.26M | 49.26M | 49.26M |
EPS (Basic) | -0.53 | -0.46 | -0.47 | -0.39 | -0.34 | -0.43 | -0.42 | -0.36 | -0.34 | -0.33 | -0.47 | -0.41 | -0.34 | -0.31 | -0.26 | -0.32 | -0.32 | -0.29 | -0.26 | -0.26 | -0.21 | -0.14 |
EPS (Diluted) | -0.53 | -0.46 | -0.47 | -0.39 | -0.34 | -0.43 | -0.42 | -0.36 | -0.34 | -0.33 | -0.47 | -0.41 | -0.34 | -0.31 | -0.26 | -0.32 | -0.32 | -0.29 | -0.26 | -0.26 | -0.21 | -0.14 |
EBITDA | -56.79M | -48.42M | -51.86M | -40.14M | -35.55M | -40.24M | -39.03M | -33.53M | -30.96M | -28M | -29.61M | -25.22M | -21.01M | -22.6M | -19.32M | -17.33M | -15.91M | -14.53M | -12.62M | -12.89M | -10.3M | -6.78M |
EBIT | -57.33M | -49.01M | -50.22M | -40.67M | -36.12M | -40.8M | -39.66M | -34.13M | -31.5M | -28.53M | -30.14M | -25.71M | -21.47M | -22.84M | -19.42M | -17.5M | -16.07M | -14.66M | -12.7M | -12.95M | -10.35M | -6.86M |
Depreciation & Amortization | 541K | 590K | -1.64M | 523K | 567K | 554K | 629K | 602K | 534K | 525K | 533K | 497K | 461K | 241K | 92K | 165K | 154K | 127K | 78K | 64K | 51K | 79K |
Add to Watchlist
Select watchlists to add or remove EWTX